XFOR(X4 Pharmaceuticals, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $0 | $0 | $0 | $2.60M | $35.11M |
| 毛利润 | — | $0 | $0 | $1.80M | $29.36M |
| 营业利润 | −$85.11M | −$87.57M | −$107.52M | −$36.40M | −$86.88M |
| 净利润 | −$88.70M | −$93.87M | −$101.17M | −$37.45M | −$79.20M |
| 经营现金流 | −$70.91M | −$77.10M | −$96.51M | −$130.90M | −$85.62M |
| 自由现金流 | −$71.52M | −$77.20M | −$96.57M | −$131.23M | −$85.62M |
| 摊薄每股收益 | $-119.70 | $-45.60 | $-17.07 | $-5.59 | $-1.87 |